The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
Baseline CTC subtype to predict outcomes on mCRPC patients (pts) receiving enzalutamide (E) compared to abiraterone (A).
 
Howard I. Scher
Leadership - Asterias Biotherapeutics
Consulting or Advisory Role - Astellas Pharma; Blue Earth Diagnostics; Clovis Oncology; Elsevier; Ferring; Janssen Research & Development; Med IQ; Medivation; Merck; Roche; Sanofi; WIRB-Copernicus Group
Research Funding - Illumina (Inst); Innocrin Pharma (Inst); Janssen (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ferring; Medivation; Roche; WIRB-Copernicus Group
 
Adam Jendrisak
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
Research Funding - Epic Sciences
 
Nicole A. Schreiber
No Relationships to Disclose
 
Brigit McLaughlin
No Relationships to Disclose
 
Ryon P Graf
Employment - Epic Sciences
Research Funding - Epic Sciences
Travel, Accommodations, Expenses - Epic Sciences
 
Angel Rodriguez
No Relationships to Disclose
 
Martin Fleisher
No Relationships to Disclose
 
Jerry Lee
No Relationships to Disclose
 
James Kelvin
Employment - Epic Sciences
Travel, Accommodations, Expenses - Epic Sciences
 
Yipeng Wang
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
Mark Andrew Landers
No Relationships to Disclose
 
Ryan Vance Dittamore
Employment - Epic Sciences
Leadership - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
Patents, Royalties, Other Intellectual Property - Patents Pending